RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer

Overview of attention for article published in Future Oncology, August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 3 news outlets

twitter: 7 X users

Readers on

mendeley: 27 Mendeley

So far, Altmetric has seen 3 news stories from 3 outlets.

News story from EX BULLETIN on Monday 16 January 2023

EX BULLETIN, 16 Jan 2023

Dramatic Increase in Cervical Cancer Research Is Driving Treatment Progress - journalbreak

journalbreak.Com, 16 Jan 2023

Despite significant advancements in prevention and screening, cervical cancer remains a fierce opponent, and the disease…

David O'Malley, MD, on Dual Immunotherapy for Advanced Cervical Cancer

MedPage Today, 09 Mar 2022

This Reading Room is a collaboration between MedPage Today® and: A novel combination of the anti-programmed death-1 (PD-1…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.